AbbVie Inc.

ABBV · Moat type: REGULIERUNG

MoatScore

5/10

Fair Value

212 USD

Margin of Safety

-22.9 %

Rating

BEOBACHTEN

AbbVie develops and commercializes biopharmaceutical products – primarily immunological, oncological, and neurological therapies – and generates revenue through the sale of prescription medications with patent protection as well as through a growing portfolio of successor products.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.